stem cell therapy for stargardt disease

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stargardt disease is the most common inherited form of juvenile macular degeneration, usually first noticed when a child or teenager begins struggling to read the board at school or complains

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stargardt disease is an inherited eye condition that slowly damages central vision. It usually begins in late childhood or early adulthood. A diagnosis can feel overwhelming, but knowing how the

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stargardt disease typically emerges in childhood or the teenage years, right as young people are navigating school, college applications, and early career decisions. With the right support and accommodations, a

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Stargardt disease is the most common inherited form of juvenile macular degeneration, caused primarily by mutations in the ABCA4 gene. As toxic byproducts accumulate in the retinal pigment epithelium (RPE)

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Yes — Stargardt disease is a genetic condition. It is the most common form of inherited juvenile macular degeneration, typically diagnosed in childhood or adolescence, though some forms appear later

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Adolescence is one of the most common periods for Stargardt’s disease to first present, and yet teenage patients face particular challenges in getting a timely, accurate diagnosis — vision changes

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience One of the most common questions families ask after a Stargardt’s disease diagnosis is simply what to expect going forward – how quickly vision may change, and what that means

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience A Stargardt’s disease diagnosis in one family member often raises immediate questions for others – about their own risk, about future children, and about what steps actually make sense to

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. B. N. Singh (General Physician, MBBS MS General Surgery, 30+ years) Gene therapy research for Stargardt’s disease has continued to develop as an active area of study, and patients and families understandably want a clear, honest sense of where things currently

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Patients newly diagnosed with Stargardt’s disease often leave their doctor’s office with a list of unfamiliar test names – fundus autofluorescence, OCT, ERG – without a clear sense of what